British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

MD Russell, M Dey, J Flint, P Davie, A Allen… - …, 2023 - academic.oup.com
Background The rationale behind this update of the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

CG Skorpen, M Hoeltzenbein, A Tincani… - Annals of the …, 2016 - ard.bmj.com
A European League Against Rheumatism (EULAR) task force was established to define
points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy …

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice

K Schreiber, M Frishman, MD Russell, M Dey… - …, 2023 - academic.oup.com
Background The rationale behind this update on the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Should pregnant women be included in phase IV clinical drug trials?

GG Briggs, JE Polifka, KL Wisner, E Gervais… - American journal of …, 2015 - Elsevier
Relatively few drugs, especially those recently approved by the US Food and Drug
Administration, have published human pregnancy experience. Although all drugs contain …

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and …

MD Russell, M Dey, J Flint, P Davie, A Allen… - …, 2023 - academic.oup.com
British Society for Rheumatology guideline on prescribing drugs in pregnancy and
breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids | Rheumatology …

A systematic review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy

H Nguyen, K Ahmed, W Luo, J Flint, I Giles - Seminars in Arthritis and …, 2021 - Elsevier
Introduction Despite increasing evidence to support safe use of tumour necrosis factor
inhibitors (TNFi) and other biologic disease modifying anti-rheumatic drugs (bDMARDs) …

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding—the British Society for Rheumatology guideline scope

I Giles, A Allen, A Crossley, J Flint, M Frishman… - …, 2021 - academic.oup.com
Ian Giles1, Alexander Allen2, Amy Crossley3, Julia Flint4, Margreta Frishman5, Mary
Gayed4, Munther Kamashta6, Louise Moore7, Sonia Panchal8, Madeleine Piper9, Clare …

A proposed framework to address needs of clinical data for informed medication use in pregnancy

DB Clemow, L Dewulf, DL Michaels… - Therapeutic …, 2014 - journals.sagepub.com
The objective of this paper is to communicate a proposed framework for addressing
research limitations and communication barriers that contribute to a lack of data for making …

Reproductive Health in the Rheumatic Diseases

J Sun, L Andreoli, J Salmon, M Clowse… - A Clinician's Pearls & …, 2023 - Springer
Few conditions in rheumatology are fraught with greater concern and more unknowns than
those of patients' fertility and pregnancy. Understanding the physiology of normal …

Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases

V Tzouma, M Grepstad, F Grimaccia… - … & Regulatory Science, 2015 - journals.sagepub.com
The increasing proportion of women conceiving later in life, associated with the higher
probability of contracting a chronic disease, highlights an increasing need to understand the …